CMR Surgical this week announced it appointed Per Vegard Nerseth as CEO, effective on Jan. 1, 2020.
Nerseth will replace Martin Frost, who will remain as CEO until the effective date and transition to a non-executive director role within the company.
Prior to joining CMR Surgical, Nerseth was senior VP and managing director of ABB Robotics. He has more than 25 years of experience in the robotics field.
“I feel privileged to be joining this vibrant, rapidly-growing, world-leading company at such an exciting stage in its development. I look forward to using my previous robotics and manufacturing experience to contribute to the future of CMR,” Nerseth said in a news release.
CMR Surgical is currently developing a universal robotic system known as Versus for minimal access surgery. The company received CE Mark approval early this year for the robotic system and recently raised $243 million in a Series C funding round.
“I am extremely proud of what we have achieved to date at CMR and I am delighted to be handing the CEO reins over to Per Vegard, who will lead the company to the next stages of its maturity. Per Vegard has strong experience in manufacturing and robotics at a multi-national level, which makes him the perfect candidate to take over. I look forward to continuing my involvement with the company as a non-executive director,” Frost said.